相关实验视频
Updated: Jul 6, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
淋巴瘤中CD30分子的作用机制和治疗向
Zhaoxia Li1, Wei Guo1, Ou Bai1
1Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in oncology
|January 8, 2024
概括
CD30是淋巴瘤治疗的关键标记物,通过NF-κB和MAPK通路促进瘤细胞存活. 了解CD30生物学为淋巴瘤患者提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 精准医学正在改变淋巴瘤治疗.
- CD30是一种跨膜蛋白,是各种淋巴瘤的关键诊断和治疗标记物.
- CD30信号传递,涉及NF-κB和MAPK等途径,增强淋巴瘤细胞存活率.
研究的目的:
- 审查淋巴瘤中CD30介导的瘤促进机制.
- 为了确定调节CD30表达的分子因素.
- 探索如何理解CD30生物学可以改善淋巴瘤治疗.
主要方法:
- 关于CD30在淋巴瘤中的作用的文献综述.
- 对CD30信号通路 (NF-κB,MAPK) 的分析.
- 对CD30表达调节的检查.
主要成果:
- CD30的上调赋予了瘤细胞的生存优势.
- 布伦图西马布维多丁 (BV) 是一种抗CD30抗体-药物联合体,可改善CD30+淋巴瘤的存活率.
- CD30的精确生物功能需要进一步阐明.
结论:
- 对CD30生物学的更深入的理解对于推进淋巴瘤治疗至关重要.
- 针对CD30提供了显著的治疗潜力.
- 对CD30机制的进一步研究可能会改善患者的治疗结果和生活质量.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

